My belief is that to keep on an even keel one has to plan
My belief is that to keep on an even keel one has to plan that everything will take the longest time possible. That way, anything out of the ordinary can only be an improvement. To put artificial timelines on events over which we have no control or complete information is just setting oneself up for major disappointment.
So for OM, we have had word that we are in negotiations with others (heavy on the s in others) as to becoming a partner, but there have also been WAGs saying that IPIX could decide to take this indication to market by themselves. So in this case, I expect the latter to happen since it would take the longest, and thus my timeline isn't in the next few weeks or months. So quit worrying about OM until a deal is signed or we at least hear about interim data from a P3 that is not even on the table yet.
IBD, we know the pill is ready to get tested in Dec. but no knowledge of when a P2 will be started nor anything about the P2 as to size. Maybe it will be a decent size, maybe it will be small to get strong interim data quickly so that a partner could be found to carry the load the remainder of the way and get IPIX the needed cash to progress in other areas, such as the K pill, the OM advancement, or dermatology related indications for B.
UPS w/ AlphaSigma - does anyone have any real clue as to a timeline for them to come up with a gel/foam and get it progressing down the line? Not holding my breath until we get some definitive word.
We have seen all too often retail timeline is so tilted to the short term that it is ridiculous. What many talk about in weeks I now look at in months. Expecting near term results plays right into the shorts attempts to make mgt look inept when those false timelines are not met.
This is not being negative in any way as I am convinced more than ever that we have a major winner on our hands, I just don't think it is going to happen as quickly as many expect.
Let the other boards be the harbingers of fast results. Let this board be the voice of non-frantic longs.
11
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Punching Above Its Weight in Massachusetts Fuel Game Man, Broco Energy isn’t just twiddling its thumbs. This Massachusetts-based, Veteran-Owned Small Business just bagged two five-year statewide fuel contracts, and they’re not just peanuts. We're talking ENE53 and ENE58 awards that cover everything from ultra-low sulfur diesel and biodiesel to plain old heating oil...
Continue Reading
Expanding Opportunities in Religious Scholarship Here's something you don't see every day: a program that's actually trying to bridge academia and the practical world. The American Council of Learned Societies (ACLS) is rolling out its second wave of their Graduate Internships on the Spiritual Infrastructure of the Future for 2027, backed by the Templeton Religion Trust....
Continue Reading
A Dual Milestone: Leadership and Recognition In an industry chock-full of buzzwords, New Story’s latest moves cut through the noise. They've just announced Adam Drudge as their new Chief People Officer, and wouldn't you know it, they've snagged their third straight Most Loved Workplace® recognition for 2026. When a special ed company starts making waves like this,...
Continue Reading
The Spotlight's on Squalane in K-Beauty Korean beauty trends are usually at the pulse of global skincare, and if you’ve been watching, there’s a new kid making waves: squalane. Now, before you wrinkle your brow wondering why this old-timer's getting all the love, let me break it down. Squalane is adding a new sheen to K-beauty’s obsession with hydration and skin...
Continue Reading
Call it a wild cosmic union or just a sharp, savvy partnership—either way, Sebastian Professional and Boiler Room have teamed up in a bold celebration of creativity that could shake things up. By leveraging their own unique legacies, they're producing "Centre Stage," a fresh content series spotlighting the explosive synergy where music and hair artistry meet. This...
Continue Reading
Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...
Continue Reading
Hell of a Pair-Up: Fedora and Clarion Focus on Oncology Well, here's a setup that doesn't scream about blue chip stocks—but it's swimming in opportunity all the same. Fedora Healthcare Solutions just shook hands with Clarion, cementing a deal that's piqued my interest for its potential to green-light some real progress for independent oncology practices. These are not...
Continue Reading
GovSignals' Strategic Leap in Defense Collaboration Tensions and possibilities always ride high when the defense sector flirtations with groundbreaking tech, and today it's GovSignals stepping into the limelight with some never-before-seen moves. With their prototype platform under Project Roundtable, they've ditched traditional routes. Admirals at the Navy must be...
Continue Reading
Unpacking Charles Tango's Move to Hydden Nobody expects cybersecurity to be a stroll in the park, and it looks like Hydden just upped its game by bringing in Charles Tango, a heavyweight turned strategy guru. You might not know him, but this guy's got a track record that shouldn’t be ignored—like a grizzled old prizefighter just itching for a new opponent. A Veteran...
Continue Reading
Nothing like waking up to the smell of lawsuits, huh? That's what Amdocs Limited (NASDAQ: DOX) investors were hit with on the morning of November 4, 2026. Watching nearly a third of your stock's value evaporate overnight—ouch. This all happened because of a classic corporate slugfest with none other than T-Mobile. Now, they're slugging it out over a supposedly...
Continue Reading
Top 5 Most Recently Viewed Articles
Asset Searches: Why They Matter to Lawyers Some days you just have to get into the nitty-gritty of legal legwork, and today feels like one of those days. Asset Search USA has come out swinging with a practical guide that no attorney should ignore, especially if they're dealing with the shadowy world of hidden assets. What are we talking about here? We're talking about...
Continue Reading
Revolutionizing Agricultural Solutions in Africa Easy Environmental Solutions Inc. is set to make a significant impact in agriculture with the introduction of its EasyFEN™ units in Africa. With a firm down payment secured on a remarkable $3.4 million order, the company is establishing its presence in the continent’s agricultural sector. This decisive step proves the...
Continue Reading
Insights into Executive Stock Purchases In the fast-paced world of finance, insider trading often grabs the attention of investors. Recently, U.S. stocks saw an upward trend, but among these changes, the activities of a few insiders have stood out. Executives making stock purchases can indicate their confidence in a company's future performance. When top leaders buy...
Continue Reading
Leadership Transition at Avance Gas Holding Ltd Avance Gas Holding Ltd is undergoing a significant change in its Board of Directors, marking a pivotal moment as the company looks to streamline its operations. The Board has appointed James Ayers and Jonathan Burnett as Directors, both currently serving in top roles at Front Ocean Management Ltd, which provides essential...
Continue Reading
Cintas Corporation Stock Performance Overview In recent developments, Cintas Corporation (NASDAQ: CTAS) has revealed notable insights through its latest earnings report. As the corporate services sector adapts to ongoing market conditions, investor perspectives are evolving. The recent results, despite exceeding earnings projections, led to a dip in stock value, which has...
Continue Reading
